HRAS and glioblastoma: Our results also showed that Chr-A could increase the accumulation of ROS and intracellular H2O2 and downregulate the expression of antioxidant proteins including Nrf-2, HO-1 and NQO-1 to trigger oxidative stress and thus curb glioblastoma progression.